HALMA ANNOUNCES NEW SECTOR VICE PRESIDENTS
November 17, 2014
Following the changes to Halma's Executive Board, including the promotion of four Sector Chief Executives (‘SCE's) to run Halma's primary business sectors, the company today confirms the appointment of three new Sector Vice Presidents (‘SVP's). Tim Prestidge Paul Simmons Todd Burt Tim Prestidge joined Halma in early November 2014 and he will work in the [...]
November 17, 2014
BOTHELL, Wash. -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), today announced it has launched two new improved packaging options for its BloodStor and CryoStor cryopreservation freeze media [...]
November 17, 2014
SOUTH SAN FRANCISCO, Calif. – Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced that the company has entered into an agreement with Illumina, Inc. (NASDAQ: ILMN). The purpose of the agreement is to commercialize an in vitro diagnostic (IVD) kit that will enable clinical laboratories to utilize [...]
Beckman Coulter Life Sciences Supports Clinical Researchers in The ONE Study
November 17, 2014
REGENSBURG, Germany -- Beckman Coulter Life Sciences is participating in the ONE Study, an international collaboration of scientists across Europe and the USA ? and holding its annual general meeting in Regensburg, Germany from19-21 November 2014. Beckman Coulter is contributing its flow cytometry expertise in cell therapy and diagnostic technologies to support the study’s specific [...]
Nikon Instruments, Inc. Announces Strategic Partnership with JEOL
November 17, 2014
Nikon Instruments, Inc. is pleased to announce a strategic partnership between Nikon and JEOL to research and develop solutions to address correlative light and electron microscopy Overcoming resolution limits imposed by the diffraction of light has been a major breakthrough in the field of light microscopy, as evidenced by the recent 2014 Nobel Prize in [...]
Riffyn Secures $1.8 Million Seed Financing to Advance Reproducible Research
November 17, 2014
OAKLAND — — Riffyn, Inc. has raised $1.8 million in a Seed financing round led by O’Reilly AlphaTech Ventures, with additional investments from Bioeconomy Capital and others. Riffyn provides experimental process design and analytics software to improve reproducibility and tech transfer in life science, chemical and materials research and development. The financing accelerates Riffyn’s efforts [...]
Dotmatics expands Global Operations with South Korean Country Manager
November 17, 2014
Bishops Stortford, UK -- Dotmatics, a leading provider of scientific informatics solutions and services, announces the appointment of James (Jong-Soo) Han as South Korean Country Manager. The successful adoption of the Dotmatics Platform by the pharmaceutical, biotech and chemical industries prompted the setup of Dotmatics’ facilities in South Korea. Mr Han brings over a decade [...]
InstantLabs releases first DNA-based Seafood identification test for Atlantic Blue Crab meat
November 17, 2014
BALTIMORE – — InstantLabs® announced today the commercial launch of its InstantID Atlantic Blue Crab DNA verification test – the first in a series of seafood species identification tests to help the global seafood industry respond to the increasing challenge of seafood fraud. The new species verification assay was created through a partnership with the [...]
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
November 17, 2014
WALTHAM, Mass.-- Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has priced its previously announced offering of €640 million aggregate principal amount of 2.000% senior notes due 2025 at an issue price of 99.680% of the principal amount. The issuance of the notes is expected to close on or about November 24, 2014, [...]
Horizon Discovery Group Signs Agreement with Top Ten Pharma Company
November 17, 2014
Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced that its Horizon CombinatoRx division has been contracted by a top ten pharma company to profile a lead oncology asset. Under the terms of the agreement, Horizon CombinatoRx [...]

